1 dead in phase I trial


One person is dead and five others are hospitalized in a phase I trial that went badly wrong. Three of the survivors may have suffered irreversible brain damage, according to Dr. Gilles Edan, head of neurology at the Centre Hospitalier Universitaire de Rennes, France, as quoted in the New York Times (Chanjan S. NY Times, Jan. 15, 2016). Preliminary MRI results showed cerebral hemorrhage and brain necrosis in some study participants.

It takes 30 seconds

Recommend to a Colleague Go back to home page